Zhang Hao, Wang Yang, Xu Tianming, Li Chen, Wu Jiang, He Qianyun, Wang Guangchao, Ding Chen, Liu Kang, Tang Hao, Ji Fang
Department of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Department of Orthopedics, General Hospital of Beijing Military Region, Beijing 100700, P.R. China.
Oncol Lett. 2016 Nov;12(5):3208-3214. doi: 10.3892/ol.2016.5050. Epub 2016 Aug 26.
Osteosarcoma is the most common type of primary malignant bone tumor, and deregulated microRNAs (miRNAs or miRs) in osteosarcoma have attracted great attention. In the present study, through miRNA microarray analysis, it was identified that miR-148a expression was significantly increased in osteosarcoma tissues. Increased miR-148a expression was significantly correlated with tumor progression and prognosis. Furthermore, increased miR-148a expression could promote osteosarcoma growth and , and the tumor-promoting effect was due to enhanced activation of the phosphoinositide 3-kinase signaling pathway caused by miR-148a-mediated inhibition of phosphatase and tensin homolog expression. Together, the present results suggest a role for miR-148a in osteosarcoma development and its potential use in prognosis prediction and cancer therapy.
骨肉瘤是最常见的原发性恶性骨肿瘤类型,骨肉瘤中失调的微小RNA(miRNA或miR)已引起广泛关注。在本研究中,通过miRNA微阵列分析,发现骨肉瘤组织中miR-148a表达显著增加。miR-148a表达增加与肿瘤进展和预后显著相关。此外,miR-148a表达增加可促进骨肉瘤生长,且这种促肿瘤作用是由于miR-148a介导的磷酸酶和张力蛋白同源物表达抑制导致磷脂酰肌醇3-激酶信号通路激活增强所致。总之,本研究结果提示miR-148a在骨肉瘤发生发展中起作用,及其在预后预测和癌症治疗中的潜在应用价值。